Guangzhou JEEP Biotechnology: difference between revisions
Diff·revision 8 → 9·05:46, 3 Oct 2024
Difference between revision 8 and revision 9 of Guangzhou JEEP Biotechnology. 6 lines changed; the page grew by 729 bytes.
| Revision 8 — 18:27, 16 Sep 2024 ReportReaderRilla (talk) correct the other-designations row — those are trading variants, not subsidiaries 4,643 bytes +33 | Revision 9 — 05:46, 3 Oct 2024 DeadSpaceDot (talk) add the storage and handling guidance the organisation publishes 5,372 bytes +729 | ||
|---|---|---|---|
| 1 | {{Infobox organisation | 1 | {{Infobox organisation |
| 2 | | name = Guangzhou JEEP Biotechnology Co., Ltd. | 2 | | name = Guangzhou JEEP Biotechnology Co., Ltd. |
| + | 3 | | image = facility.svg | |
| + | 4 | | caption = Schematic synthesis and quality-control site. No image of this organisation's premises is available to this wiki. | |
| 3 | | Legal name = Guangzhou JEEP Biotechnology Co., Ltd. | 5 | | Legal name = Guangzhou JEEP Biotechnology Co., Ltd. |
| 4 | | Trading name = JEEP | 6 | | Trading name = JEEP |
| ⋮ | ⋮ | ||
| 27 | The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report. | 29 | The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report. |
| 28 | 30 | ||
| + | 31 | == Operations and documentation practice == | |
| + | 32 | Purchaser reports describe lyophilised material in crimped glass vials with a batch certificate, insulated packaging and a cold pack.{{r|reports}} Certificate content in the submitted set has been comparatively complete for a retail supplier: purity and appearance consistently, water on most lots, and a method statement on some.{{r|usp1503}} | |
| + | 33 | ||
| 29 | == References == | 34 | == References == |
| 30 | {{reflist}} | 35 | {{reflist}} |
| ⋮ | ⋮ | ||
| 33 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> | 38 | <ref name="reports">Independent test reports submitted to PeptidePedia by purchasers, 2024–2026. Individual reports on individual samples; they are not a sample of the organisation's output and cannot support a claim about it. See [[Blind sampling]].</ref> |
| 34 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> | 39 | <ref name="tally">PeptidePedia reception tally (self-reported submissions; '''weak evidence''' — see [[Project:Sourcing guidelines]]). Self-selected sample; period and count stated at each point of use.</ref> |
| + | 40 | <ref name="usp1503">United States Pharmacopeia, General Chapter <1503>, "Quality Attributes of Synthetic Peptide Drug Substances" (informational). USP–NF, current revision.</ref> | |
| 35 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> | 41 | <ref name="ruo">Research-use-only labelling practice; see [[Research use only]] for the legal and commercial function of the phrase.</ref> |
| 36 | 42 |